Are conventional and hypofractionated chemoradiotherapy comparable in glioblastoma patients?

Di Guglielmo FC, Bonaparte I, Davì V, Guida P, Ciliberti MP, Gregucci F, Surgo A, Caliandro M, Carbonara R, Giraldi D, Fanelli V, Surico G, Gentile MA, Calbi R, Internò V, Laera L, Talienti T, Signorelli F, Lombardi G, Fiorentino A

Open source

DOI: 10.1007/s12094-025-04107-5
Published: 2026 Apr
Container: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12094-025-04107-5,
  title = {Are conventional and hypofractionated chemoradiotherapy comparable in glioblastoma patients?},
  author = {Di Guglielmo FC and Bonaparte I and Davì V and Guida P and Ciliberti MP and Gregucci F and Surgo A and Caliandro M and Carbonara R and Giraldi D and Fanelli V and Surico G and Gentile MA and Calbi R and Internò V and Laera L and Talienti T and Signorelli F and Lombardi G and Fiorentino A},
  year = {2026},
  journal = {Clinical \& translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico},
  doi = {10.1007/s12094-025-04107-5},
  url = {https://doi.org/10.1007/s12094-025-04107-5}
}

RIS

TY  - JOUR
TI  - Are conventional and hypofractionated chemoradiotherapy comparable in glioblastoma patients?
AU  - Di Guglielmo FC
AU  - Bonaparte I
AU  - Davì V
AU  - Guida P
AU  - Ciliberti MP
AU  - Gregucci F
AU  - Surgo A
AU  - Caliandro M
AU  - Carbonara R
AU  - Giraldi D
AU  - Fanelli V
AU  - Surico G
AU  - Gentile MA
AU  - Calbi R
AU  - Internò V
AU  - Laera L
AU  - Talienti T
AU  - Signorelli F
AU  - Lombardi G
AU  - Fiorentino A
PY  - 2026
JO  - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
DO  - 10.1007/s12094-025-04107-5
UR  - https://doi.org/10.1007/s12094-025-04107-5
ER  -

APA

FC, D. G., I, B., V, D., P, G., MP, C., F, G., A, S., M, C., R, C., D, G., V, F., G, S., MA, G., R, C., V, I., L, L., T, T., F, S., G, L., & A, F. (2026). Are conventional and hypofractionated chemoradiotherapy comparable in glioblastoma patients?. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. https://doi.org/10.1007/s12094-025-04107-5

Source records

pubmed · retrieved 2026-09-25T17:47:33.011Z